Pharmafile Logo
Pharmafocus logo
Advanced Search

Stada

Showing 8 posts of 8 posts found.

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025
Research and Development Bio-Thera, Immunology, Stada

STADA and Bio-Thera’s Gotenfia (golimumab), a biosimilar of Janssen’s Simponi, has received a positive opinion from the European Medicines Agency …

News

STADA appoints Ole Wendler Pedersen as Executive VP Legal and General Counsel

December 8, 2025
Executive VP Legal and General Counsel, Stada

German pharmaceutical company STADA has announced the appointment of Ole Wendler Pedersen as its new Executive Vice President Legal and …

Appointment
takeda_usa_pharmaceuticals_u

Takeda to jettison non-core asset portfolio to Stada for $660 million

November 6, 2019
Research and Development, Sales and Marketing Stada, Takeda, pharma

Takeda has announced it is divesting a portfolio of its over-the-counter (OTC) and prescription drug products to Stada for a …

News
peter_goldschmidt_web

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …

Appointment

Stada takeover back in motion after revised bid

July 12, 2017
Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical

Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …

News

Stada CEO and CFO tumble in takeover turmoil

July 4, 2017
Sales and Marketing Bain capital, Cinven, Stada

Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …

News

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017
Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …

News

Grunenthal in talks to sell pain drug portfolio

May 19, 2011
Sales and Marketing Grunenthal, Stada, chronic pain, pain therapeutics

Grunenthal is negotiating a 360 million euro deal to sell Central and Eastern European rights to some of its pain …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026